Urgent

Continuous renal replacement therapy (CRRT / haemofiltration)

CRRT · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Continuous veno-venous haemofiltration (convection ± dialysis = CVVHDF) via a double-lumen catheter: gentle continuous fluid and solute control suited to unstable ICU patients — the standard ICU modality (intermittent HD suits stable patients; PD is largely superseded in adult ICU).

Red flags

  • Do NOT delay CRRT for a dialysable life-threat while “optimising”
  • Citrate toxicity: rising total:ionised calcium ratio, worsening acidosis

Management

  • Urgent indications: refractory hyperkalaemia >6.5, refractory acidosis, diuretic-resistant fluid overload, uraemic complications (pericarditis/encephalopathy), selected toxins (SLED/HD for lithium, toxic alcohols)
  • Prescribe effluent dose 20–25 mL/kg/h (higher doses show no benefit — RENAL/ATN trials); pre/post-dilution per circuit
  • Anticoagulation: regional citrate (first-line where available — watch ionised calcium and citrate accumulation) or heparin; none if coagulopathic
  • Vascular access: right IJ preferred; avoid subclavian (stenosis)
  • Watch: hypotension on connection, hypophosphataemia/hypokalaemia with prolonged therapy, drug dose adjustments, circuit clotting

Exam pearls

  • 2020s update: accelerated (pre-emptive) initiation shows no benefit over watchful waiting with clear triggers (STARRT-AKI 2020)

Continuous, gentle, titratable — the unstable kidney’s best friend; dose ~25 mL/kg/h and protect the circuit.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.